The cytokine-transforming growth factor beta1 (TGFB1) is implicated in development of the mammary gland through regulation of epithelial cell proliferation and differentiation during puberty and pregnancy. We compared mammary gland morphogenesis in virgin Tgfb1 þ/þ , Tgfb1
INTRODUCTION
Mammary gland development is a finely orchestrated event involving hormone-regulated proliferation, differentiation, and tissue remodeling. The rudimentary epithelial ductal tree present at birth extends and branches through the mammary gland fat pad during puberty, under the control of estrogen [1] . While hormonal regulation of mammary gland development during puberty and pregnancy is paramount, local paracrine and autocrine factors have essential interlocutory roles.
Branching morphogenesis is a key feature of postnatal mammary gland development. Bifurcation, or primary branching, of the active proliferative component of the duct, the terminal end bud, occurs as the duct elongates and is regulated by local growth factors and extracellular matrix deposition and degradation [2, 3] . Lateral secondary branching occurs as side branches arise from the primary ducts. Under the control of progesterone, the gland undergoes tertiary branching at diestrus and during pregnancy [4] , whereby alveolar structures begin to take shape in preparation for potential lactation capability.
The transforming growth factor beta1 (TGFB1) family of cytokines regulate a diverse range of epithelial cell processes, including proliferation, apoptosis, and differentiation [5] [6] [7] . TGFB1 is highly expressed by mammary epithelium in puberty and adulthood and during pregnancy-induced alveolar morphogenesis, with diminished expression evident in the lactating gland [8] . Analysis of phenotypes of transgenic mice with impaired TGFB family signaling targeted to the mammary gland epithelium have indicated that the three isoforms of TGFB (TGFB1, TGFB2, and TGFB3) can act to regulate mammary gland epithelial cell proliferation and differentiation during both puberty and pregnancy [9] [10] [11] [12] . Importantly, reduced expression of the TGFB1 isoform in mice heterozygous for the Tgfb1 null mutation has been reported to result in increased epithelial ductal invasion during pubertal mammary gland development, associated with accelerated epithelial proliferation [13] . Recently TGFB1 also has been identified as a key regulator of branch spacing [14] . Using an in vitro three-dimensional assay to reconstruct mammary gland ductal epithelium, local gradients of TGFB1 were found to control the positional context of ductal birfurcation and lateral branching.
Analysis of the effect of complete deficiency in the TGFB1 isoform on mammary gland development during puberty and adulthood has been difficult, because mice carrying a null mutation of the Tgfb1 gene (Tgfb1 À/À ) die at 3 wk of age because of multiorgan inflammation caused by dysregulated immune function [15, 16] . The pathological phenotype, however, can be rescued by rendering the mice immunocompromised [17] . Using mice on a severe combined immunodeficient background, we have been successful in maintaining Tgfb1 null mutant mice to adulthood, allowing reproductive function to be explored. Female Tgfb1 null mutant mice exhibit delayed onset of sexual maturation, disrupted estrous cycles, and arrested preimplantation embryo development, leading to almost complete infertility [18] . Ovulation is impaired secondary to reduced LH secretion, and after ovulation, the mice have reduced capacity to produce progesterone.
Here, we report our findings on mammary gland development in virgin mice carrying a null mutation in the Tgfb1 gene. Our transplantation data support previous literature reporting that autocrine sources of TGFB1 inhibit epithelial growth during puberty. Because ductal extension proceeds at a normal rate in Tgfb1 null mutant mice, however, an additional, opposing role for TGFB1 in provision of systemic or stromal support for epithelial duct growth is likely to exist.
MATERIALS AND METHODS

Mice
All animal experiments were approved by the University of Adelaide Animal Ethics Committee and were conducted in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes (7th ed., 2004). Heterozygous (Tgfb1 þ/À ) breeding pairs on a mixed CF1/129/C3H background produced progeny that were homozygous for a targeted null mutation in the Tgfb1 gene (Tgfb1
), or homozygous wild type (Tgfb1 þ/þ ). All offspring were homozygous for the Prkdc scid mutation. The colony was maintained in specific, pathogen-free conditions under controlled light (12L:12D photoperiod) and temperature. Adult C57BL/6 males (Central Animal House, University of Adelaide) were used as studs in mating experiments.
The genotype of each mouse was determined by PCR of tail DNA as described previously [18] . Briefly, the PCR detected the intact and disrupted Tgfb1 gene, using the forward primer 5 0 -GAGAAGAACTGCTGTGTGCG together with the reverse primers 5 0 -GTGTCCAGGCTCCAAATATAGG to detect the intact Tgfb1 gene or 5 0 -CTCGTCCTGCAGTTCATTCA to detect the mutant Tgfb1 gene containing a neomycin-resistance gene (Neor) inserted into exon 6.
Female mice were observed daily from the time of weaning for appearance of the vaginal opening. Estrous cycles were monitored by daily histological analysis of vaginal smears in adult females [19] .
Serum Hormone Analysis
Serum progesterone and estradiol concentrations were measured using the commercial RIA kits (Diagnostic Systems Laboratories) DSL-4800 and DSL-3400, respectively, according to the manufacturer's instructions. All samples were measured in a single assay. The lower limits of detection for the estradiol and progesterone assays were 8 pM and 0.3 nM, respectively, and the withinassay variation was 10.0% and 7.9%, respectively.
Mammary Gland Whole-Mount Analysis
Fourth-pair mammary glands were dissected from killed animals at various stages of development as specified. The tissue was stretched on a glass slide and fixed in Carnoy fixative. The glands were stained with carmine alum according to previously described methods [20] .
The whole mounts were photographed on a Leica MZ16FA Steriomicroscope (Adelaide Microscopy) and analyzed using ImageJ software [21] , with the user blinded to the genotype. Terminal end buds, defined as club-like structures protruding from the distal end of the ducts, were counted in mammary glands from peripubertal animals. The lengths of three main ducts in each virgin estrous mammary gland were measured, and the number of branch points along each duct was used to calculate the extent of branching, given as branch points per millimeter. The three branch points per millimeter in each mammary gland were averaged to give a single value for each animal.
Mammary Gland Transplants
Mammary gland transplants were performed using 8-wk-old Tgfb1 þ/þ and Tgfb1 À/À donor mammary tissue. The mice were killed, and the inguinal mammary gland was excised. Small (1-mm 3 ) portions were cut from the middle region of the gland, then rinsed and stored in ice-cold PBS. Endogenous mammary gland tissue was removed from the fat pad of 24-day-old, wild-type CB.17 Prkdc scid females (ARC) under 2% Avertin anesthesia, and the small portion of donor mammary gland was transplanted into the cleared fat pad. Tgfb1 þ/þ and Tgfb1 À/À mammary tissue was inserted into the mammary gland of the same recipient animal on contralateral sides. The transplants were performed on three separate occasions using three different Tgfb1 À/À and Tgfb1 þ/þ donors to generate a total of 30 recipient mice. Recipient mice were segregated into three cohorts. The first cohort was killed at the age of 6 wk (i.e., 3 wk after transplant). The second cohort was killed at 12 wk of age during the estrous phase of the ovarian cycle. The third cohort was mated with stud males and killed at Day 18 postcoitus. Mammary glands were dissected and either stained with carmine alum for whole-mount analysis or paraffin embedded and stained with hematoxylin and eosin.
Immunohistochemistry and Assessment of Proliferation of Mammary Glands
One hour before they were killed, mice were given 100 ll i.p. of a 10 mg/ml solution of bromodeoxyuridine (BrdU; Sigma). Mammary glands were fixed overnight in 4% paraformaldehyde and embedded in paraffin. Serial sections (thickness, 7 lm) were cut, and every eighth slide was stained with hematoxylin and eosin. The location of terminal end buds was identified in these sections, and adjacent sections were used for further analysis of terminal end bud histology.
Sections were stained for BrdU incorporation into DNA using a BrdU InSitu Detection Kit (BD Pharmingen) according to the manufacturer's instructions. Incorporation of BrdU as a measure of proliferation was quantified in terminal end buds using Video Pro 32 software (Leading Edge). Percentage positivity was determined within each terminal end bud. Between two and four terminal end buds from each mammary gland were assessed, and data were averaged to give a single value for each mouse.
Other sections were stained with the macrophage-and eosinophil-specific antibody F4/80 (Caltag). After dewaxing and rehydrating the section, F4/80 antibody was incubated with the slide at a dilution of 1:50 at 48C overnight. After washing in PBS, the slides were incubated with biotinylated rabbit anti-rat secondary antibody at 1:100 for 40 min at room temperature. After washing, the slides were incubated with the Vectastain Elite ABC kit (Vector Laboratories) according to manufacturer's instructions, and diaminobenzidine staining followed. Standard counterstaining with hematoxylin and mounting followed.
Statistical Analysis
Data were analyzed using Student t-test and the Tukey post hoc test with SPSS 13 for Windows software (SPSS Inc.). Significance was inferred at P , 0.05.
RESULTS
Pubertal Development in Tgfb1 Null Mutant Mice
Effect of Tgfb1 null mutation on pubertal mammary gland development at 6 wk. Initially, mammary gland development was assessed in 6-wk-old, peripubertal mice. A similar extent of ductal extension was found in Tgfb1 þ/þ and Tgfb1 þ/À mice (18.4 6 0.7 mm, n ¼ 6, and 18.3 6 0.6 mm, n ¼ 5, respectively [values are mean 6 SEM throughout]). A significant delay in ductal elongation in Tgfb1 À/À mice was observed (8.8 6 1.2 mm, n ¼ 8, P , 0.001). The onset of sexual maturity in Tgfb1 À/À females, however, as measured by age of appearance of vaginal opening and age at first proestrus, was delayed by approximately 1 wk [18] . Because estrogen is the principal driver of mammary gland development during the peripubertal period [22, 23] , this raised the question of whether delayed mammary gland development was associated with delayed sexual development.
Vaginal opening as a marker for pubertal mammary gland developmental stage. To evaluate mammary gland development in Tgfb1 þ/þ and Tgfb1 À/À mice relative to age at puberty, we used age at appearance of the vaginal opening as a physical marker of sexual development. Initially, ductal extension in Tgfb1 þ/þ mice was analyzed at a range of time points between 2 and 12 days after vaginal opening. A positive correlation was found between days after vaginal opening and ductal length (n ¼ 10, R ¼ 0.74, P ¼ 0.014). Age and ductal length also correlated (R ¼ 0.90, P ¼ 0.0004). Mouse weight and serum estradiol concentration at death did not correlate with ductal length during this period (R ¼ 0.06, P ¼ 0.87, and R ¼ 0.40, P ¼ 0.26, respectively). Between 2 and 12 days after vaginal opening, ductal extension progressed at a rate of 0.83 mm/day (although it should be noted this is an underestimate of ductal elongation rate, because dehydrated whole mounts shrink during processing). It therefore was concluded that mammary gland development at 7 days after appearance of the vaginal opening (d7 post-VO) was a suitable parameter to evaluate to account for the variation in onset of sexual maturity in Tgfb1
À/À mice.
Normal pubertal mammary gland development in Tgfb1 null mutant mice.
, and Tgfb1
À/À female mice were dissected on d7 post-VO (n ¼ 6, 9, and 5, respectively). Examples of mammary gland whole mounts are represented in Figure 1 , A-C. No significant difference in age at d7 post-VO was found between Tgfb1
and Tgfb1 þ/À females (37 6 1 and 35 6 1 days, respectively; P ¼ 0.14). In Tgfb1 À/À mice, d7 post-VO occurred 5 days later than in Tgfb1-replete mice (P ¼ 0.008) ( Table 1) , consistent with previous observations [18] . No difference in body weight or serum estradiol was found between the genotypes; however, serum progesterone was reduced in Tgfb1 À/À mice (P ¼ 0.042) ( Table 1) . Percentage of the mammary fat pad filled was not
, or Tgfb1 À/À mice (61% 6 5%, 54% 6 4%, and 52% 6 4%, respectively), and neither was ductal length (Fig. 1D) . A significant reduction was found, however, in the number of terminal end buds in Tgfb1 À/À mice compared with both Tgfb1 þ/þ (P ¼ 0.041) and Tgfb1 þ/À mice (P ¼ 0.009) (Fig. 1E) .
Terminal end buds in tissue from d7 post-VO Tgfb1 À/À mice appeared to be of normal structure and cellular composition compared to terminal end buds from Tgfb1 þ/þ mice, with cap cells, body cells, and myoepithelia present in the expected locations (Fig. 2, A and B) . A similar extent of proliferation in body cells, as measured by BrdU incorporation, also was observed (Fig. 2, A-C) . The F4/80-positive macrophages and eosinophils were found in similar abundance around the terminal end buds of Tgfb1 þ/þ and Tgfb1 À/À mice (Fig. 2, D  and E, respectively) .
Effect of epithelial Tgfb1 null mutation on pubertal mammary gland development. To investigate the role of autocrine sources of TGFB1 on ductal epithelial development, mammary gland tissue from Tgfb1 wild-type or null mutant mice were transplanted into the cleared fat pad of 3-wk-old, wild-type mice. Epithelial stem cells from the donor are able to repopulate the cleared fat pad of the recipient; however, the stroma is of recipient origin. To analyze pubertal development, the recipients were killed 3 wk after transplant, when they were 6 wk of age. The transplanted mass was evident in each recipient fat pad after staining with carmine alum, and in more than 80% of these, donor epithelium was observed growing out from this mass, irrespective of donor genotype. Epithelium from Tgfb1 null mutant mice was found to extend farther into the recipient fat pad than epithelium from wild-type mice, covering a 3-fold larger area (P ¼ 0.02) (Fig. 3 ) and resulting in a greater percentage of fat pad filled by Tgfb1 null epithelium (5.3% 6 2.2% and 13.2% 6 2.3% for Tgfb1 þ/þ and Tgfb1 À/À , respectively; P ¼ 0.04). Neither ductal length (1.6 6 0.6 and 2.8 6 0.4 mm for Tgfb1 þ/þ and Tgfb1 À/À , respectively; P ¼ 0.12) or number of terminal end buds (5 6 2 and 9 6 2 for Tgfb1 þ/þ and Tgfb1 À/À , respectively; P ¼ 0.11) were significantly increased. The modest increase in both of these parameters, however, likely contributed to the accelerated filling of the fat pad.
Virgin Adult Mammary Gland Development in Tgfb1 Null Mutant Mice
Effect of Tgfb1 null mutation on mammary gland morphology at estrus. To evaluate the effect of Tgfb1 null mutation on virgin adult mammary gland structure, whole mounts from 12-wk-old Tgfb1 þ/þ and Tgfb1 À/À females were prepared. At the age of 12 wk, some Tgfb1 À/À females (6 of 15) were found not to be showing signs of estrous cycling. Noncycling animals displayed a rudimentary mammary gland ductal tree, with few epithelial branches (data not shown). These animals would be expected to have greatly altered serum estradiol and progesterone levels, and because mammary gland development and maintenance is dependent on these hormones, noncycling animals were excluded from further analysis. Mammary glands were dissected from mice at either estrus or diestrus, as determined by the cellular composition of vaginal smears. At estrus, Tgfb1 À/À mammary glands were similar to Tgfb1 þ/þ mammary glands in overall appearance (Fig. 4, A and B ) and in branching (n ¼ 5 per group, P ¼ 0.18) (Fig. 4C) . At estrus, Tgfb1 À/À mice had lowered serum progesterone compared to Tgfb1 þ/þ mice (5.3 6 1.3 nM compared to 15.9 6 2.0 nM, P ¼ 0.001) and similar levels of serum estradiol (123.4 6 12.9 pM compared to 152.0 6 8.9 pM, P ¼ 0.10).
Effect of epithelial Tgfb1 null mutation on virgin adult mammary gland development. To examine the role of epithelial sources of TGFB1 in the virgin adult mammary 
, and Tgfb1 À/À females (n ¼ 6, 9, and 5 per group, respectively). Data are presented as the mean 6 SEM (*P , 0.05). Bar ¼ 5 mm. MAMMARY GLAND DEVELOPMENT IN Tgfb1 NULL MICE gland, mammary glands from Tgfb1 À/À and Tgfb1 þ/þ adult females were transplanted into the cleared mammary fat pads of 24-day-old, wild-type recipients. In estrous recipients evaluated at 12 wk of age, the transplanted mammary gland tissue from both Tgfb1 þ/þ and Tgfb1 À/À donors was found to have fully expanded through the recipient fat pad (Fig. 4 , D and E), and the same degree of ductal branching was observed (n ¼ 5, P ¼ 0.99) (Fig. 4F) .
Effect of Tgfb1 null mutation on mammary gland morphology at diestrus. Mammary glands from Tgfb1
and Tgfb1 À/À mice also were evaluated at diestrus (Fig. 5, A and B, respectively, for whole mounts and Fig. 5 , C and D, respectively, for staining with hematoxylin and eosin). Tertiary branching and alveolar structures were apparent in Tgfb1 À/À mammary glands but were observed less frequently compared with Tgfb1 þ/þ glands. At this stage of the estrous cycle, serum estradiol was similar between Tgfb1 þ/þ and Tgfb1 À/À mice (72.6 6 22.7 and 60.9 6 20.0 pM, respectively); however, serum progesterone was significantly reduced in Tgfb1 À/À mice (77.3 6 27.9 and 2.5 6 0.4 nM, n ¼ 4 per group, P ¼ 0.04).
Effect of Epithelial Tgfb1 Null Mutation on PregnancyInduced Development
A third cohort of recipient mice, transplanted with mammary gland from Tgfb1 À/À and Tgfb1 þ/þ adult females, were mated with stud wild-type males. The appearance of a mating plug was indicative of Day 1 of pregnancy. Mammary glands dissected on Day 18 of pregnancy revealed that Tgfb1 À/À and Tgfb1 þ/þ transplanted mammary gland tissue had undergone a similar degree of pregnancy-induced development of alveolar structures (Fig. 6, A and B) . It was not possible to fully evaluate lactation function, because transplanted mammary tissue does not drain to a nipple. The structure of the tissue in late gestation, however, appeared to be consistent with milk synthesis.
DISCUSSION
These experiments show that while mammary gland development is delayed in mice that are genetically deficient in the cytokine TGFB1, once initiated it proceeds in a manner that appears both structurally and temporally similar to development in TGFB1-replete mice. Elongation of epithelial ducts into the mammary fat pad occurs normally, giving rise to adult tissue that is indistinguishable from that of wild-type controls. By no means, however, is TGFB1 redundant in mammary gland morphogenesis. Transplantation studies reveal that TGFB1-deficient epithelium, when allowed to develop in a TGFB1-replete environment, exhibits accelerated development compared with wild-type epithelium. This finding indicates two opposing actions of TGFB1 in mammary gland morphogenesis: autocrine inhibition of epithelial duct growth, and endocrine or paracrine stimulation of epithelial duct growth.
Infertility and Hormone Imbalance in the Absence of TGFB1
Investigations into the effect of TGFB1 deficiency on mammary gland development are confounded by impaired development and hypothalamic-pituitary-gonadal axis signaling that results from the absence of this cytokine. A delay in sexual maturity occurs in Tgfb1 null mutant mice and is thought to result from altered growth trajectory during postnatal life [18] . The reduction in ductal elongation at 6 wk of age in Tgfb1 null mutant mice can be fully attributed to delayed onset of puberty, because when this is corrected for, a similar rate of ductal extension is observed. In Tgfb1 null mutant females, a reduction in circulating levels of LH is found at proestrus, estrus cycles are approximately doubled in length, and progesterone output from the ovary is reduced [18] . The fewer numbers of terminal end buds during puberty and reduced tertiary branching in Tgfb1 null mutant mice during the diestrous phase of the ovarian cycle might be a secondary consequence of reduced circulating levels of progesterone [4, 24] . Hormone replacement studies are necessary to confirm this.
The role of TGFB1 in mammary development during pregnancy has been difficult to investigate in our model given the severely impaired fertility of Tgfb1 null mutant mice. Our previous studies have shown that when housed with stud males, 60% of Tgfb1 null mutant females fail to mate in a 3-wk period. Of these, only 20% gave birth to live litters [18] . In total, we have observed three Tgfb1 null mutant females (out of 34 Tgfb1 null mutant female mice evaluated) give birth to litters. In two litters, the pups failed to thrive and died within 7 days. The third litter was surrogated to a normal lactating female, and the pups grew to healthy adulthood (unpublished observations). A lactation defect might have been the cause of failure to thrive, but other possibilities, such as lack of maternal care, could not be ruled out.
Because of these confounding developmental and hormonal aberrations in Tgfb1 null mutant mice, a transplant approach was taken to investigate the effect of TGFB1 epithelial deficiency on mammary gland morphogenesis.
Autocrine Inhibition of Epithelial Growth by TGFB1
Transplantation of donor mammary gland epithelium from Tgfb1 null mutant and wild-type control mice into TGFB1-replete host mammary gland fat pads yielded informative results. Ductal epithelium from Tgfb1 null mutant mice showed accelerated expansion, and autopsy performed 3 wk after transplant showed the tissue had infiltrated a 3-fold greater area of fat pad compared with epithelium from wild-type control mice. Neither ductal length nor terminal end bud number was significantly increased; however, in combination, these two parameters contributed to the significant increase in ductal area.
Previous studies have shown that overabundance of TGFB1 by insertion of TGFB1-bearing implants or Tgfb1 transgene expression targeted to the mammary gland caused reversible terminal end bud regression [25] and reduced ductal growth rate associated with decreased proliferation of terminal end bud epithelium [26] . Conversely, lowered TGFB1 expression caused increased epithelial proliferation and ductal extension in pubertal mice [13] . Furthermore, inhibition of TGFB signaling by expression of a dominant negative receptor on mammary gland epithelial cells caused alveolar hyperplasia and inappropriate milk protein expression in virgin mice [11] as well as accelerated mammary gland differentiation in early pregnancy and delayed postlactational involution [10] . The TGFB-mediated inhibition of epithelial proliferation was independent of SMAD3 [27] and recently was shown to involve WNT5A [28] . Our studies are consistent with these previous findings and provide further support for a predominantly inhibitory role of TGFB1 in autocrine regulation of epithelial proliferation and growth.
Endocrine or Paracrine Regulation by TGFB1
In light of the increased epithelial growth resulting from autocrine TGFB1 deficiency in wild-type recipients, the normal epithelial growth observed in Tgfb1 null mutant mice must be attributed to an opposing role for systemic TGFB1, which acts to promote epithelial proliferation. This might be mediated by a reduction in circulating hormones or the stromal cells that surround the terminal end bud and regulate its growth. The hormonal environment in Tgfb1 null mutant mice is suboptimal, and this might contribute to reduced epithelial growth. However, the principal driver of terminal end bud elongation, serum estradiol, was comparable during puberty, and later onset of puberty in Tgfb1 null mutant mice was controlled for in these experiments. Thus, other unidentified effects of TGFB1 deficiency might affect mammary gland morphogenesis.
It might be that TGFB1 provides critical regulation of stromal cells that support epithelial cell function. Likely candidate cells that require TGFB for normal functioning are fibroblasts. These cells surround the developing ductal tree and provide support for epithelial growth. Null mutation in TGFB type II receptor targeted to fibroblasts results in reduced terminal end bud epithelial proliferation and reduced pubertal ductal branching and elongation [29] . Other stromal cell types potentially affected by TGFB1 deficiency are macrophages and eosinophils, both of which support pubertal epithelial growth [30] . Macrophages and eosinophils were similarly abundant around the terminal end buds of Tgfb1 null mice, although their phenotype and function may be altered in a TGFB1-deficient environment.
Tgfb1 Null Mutation Has Strain-Dependent Effects
Studies of Tgfb1 heterozygous mice by Ewan et al. [13] implicate the TGFB1 isoform in autocrine regulation of mammary epithelial cell proliferation, but those authors did not observe the effects of systemic TGFB1 deficiency reported here. In heterozygous mice (Tgfb1 þ/À ), both latent and active TGFB1 protein are reduced by 70% in the mammary gland at puberty and at adult estrus. Reduced TGFB1 caused faster growth of terminal end buds through the mammary gland fat pad during puberty, associated with increased proliferation of terminal end bud epithelial cells. More rapid outgrowth of Tgfb1 þ/À mammary tissue transplanted into Tgfb1-replete host also was observed, demonstrating dependence of epithelial cells on autocrine sources of TGFB1. Whereas our studies with Tgfb1 null transplanted epithelium confirmed these findings, we did not find differences in mammary gland growth rate in
Tgfb1
þ/À females. Our heterozygous mice exhibit normal onset of puberty and normal fertility [18] . It is well established that phenotypes of Tgfb1 null mutant mice are highly dependent on genetic modifiers [31] [32] [33] . The disparity between our results and those of Ewan et al. [13] might be caused by genetic modifiers in the different background strains of the experimental mice (mixed 129S2/C57BL/6 background [13] compared to mixed CF1/129/C3H Pkrdc scid background in the present study). This might cause a different pattern of TGFB1 expression in heterozygous mice or a difference in responsiveness of systemic/stromal cells to lower levels of TGFB1.
In conclusion, taken together, these observations indicate that the cytokine TGFB1 has two distinct opposing roles in mammary gland morphogenesis. TGFB1 expressed in the epithelium appears to inhibit growth of epithelial cells in an autocrine manner. Conversely, TGFB1 is necessary for stimulation of pubertal ductal development through regulation of cells systemically or within the stroma that support epithelial function. The result of these two opposing actions of TGFB1 is overtly normal mammary gland morphogenesis in pubertal Tgfb1 null mutant mice. When Tgfb1 null epithelium is removed from the constraints of a Tgfb1 null environment, however, increased ductal development occurs. The present study reveals the complex nature of the role of TGFB1 in regulation of mammary gland morphogenesis, and it provides insight regarding opposing and paradoxical findings on the role of TGFB1 in breast cancer development [34, 35] .
